Gary S. Hogge serves as Executive at Lineage Cell Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Gary S. Hogge has executed 9 insider transactions totaling $1.3M, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 11, 2023 involved selling 5,310 shares valued at $7.2K.
Gary S. Hogge currently holds 7,710 shares of Lineage Cell Therapeutics, Inc. (LCTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gary S. Hogge has been a net seller of LCTX stock. They have purchased $0 and sold $1.3M worth of shares.
Gary S. Hogge's most recent insider trade was on Feb 11, 2023, when they sold 5,310 shares at $1.35 per share.
Get notified when new Form 4 filings are submitted
| 13,020 |
| $N/A |
| Discretionary |
| Dec 29, 2021 | LCTX | $69.4K | Sale | 28,445 | $2.44 | Discretionary |
| Dec 29, 2021 | LCTX | $23.0K | Sale | 9,250 | $2.49 | Discretionary |
| Dec 29, 2021 | LCTX | $6.4K | Option Exercise | 9,250 | $0.69 | Discretionary |
| Dec 28, 2021 | LCTX | $1.2M | Sale | 501,588 | $2.45 | Discretionary |
| Dec 28, 2021 | LCTX | $90.8K | Option Exercise | 79,689 | $1.14 | Discretionary |
| Dec 28, 2021 | LCTX | $499.9K | Option Exercise | 236,899 | $2.11 | Discretionary |
| Dec 28, 2021 | LCTX | $127.7K | Option Exercise | 185,000 | $0.69 | Discretionary |